Journal profile · MEDICINE, GENERAL & INTERNAL
Diagnostic and Prognostic Research
ISSN 2397-7523 · BMC · United Kingdom
Diagnostic and Prognostic Research: CAS Zone 3 · Medicine (2026 Xinrui edition); impact factor 3.9 (journal website); fully open access; APC about USD 2,890; median 201 days to acceptance (56 articles, last 24 months); 33 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
Diagnostic and Prognostic Research is published by BMC and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Sepsis Diagnosis and Treatment, Meta-analysis and systematic reviews and Machine Learning in Healthcare, together about 29.7% of its articles. Its main subfields are Statistics and Probability. (generated from OpenAlex topic counts and CAS ranking data)
Diagnostic and Prognostic Research encompasses diagnostic and prognostic research addressing studies on the evaluation of medical tests, markers, prediction models, decision tools and apps. Diagnostic and Prognostic Research provides a platform for disseminating empirical primary studies, systematic reviews (including meta-analyses) as well as articles on methodology, protocols and commentaries addressing diagnostic and prognostic studies. The journal ensures that the results of all well-conducted diagnostic and prognostic research are published, regardless of their outcome.
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, GENERAL & INTERNAL
Editor-in-chief Gary CollinsPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Sepsis Diagnosis and TreatmentMedicine12.5%
- Meta-analysis and systematic reviewsDecision Sciences8.8%
- Machine Learning in HealthcareComputer Science8.4%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance7.2%
- Advanced Causal Inference TechniquesMathematics6.3%
- Artificial Intelligence in Healthcare and EducationMedicine5%
- Statistical Methods and InferenceMathematics4.7%
- Statistical Methods and Bayesian InferenceMathematics4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Medicine, General & Internal | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
CASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 3.9Publisher website ·
- Impact factor (publisher) 2024
- 2.6Publisher website ·
- h-index
- 35OpenAlex ·
- i10-index
- 88OpenAlex ·
- 2-year mean citedness
- 4.91OpenAlex ·
- Self-citation rate
- 2.6%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 27LetPub ·
- Downloads per year (publisher) 2025
- 224,600Publisher website ·
Articles by year OpenAlex count · 237 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 24 | 24 | 19 |
| 2025 | 33 | 33 | 131 |
| 2024 | 18 | 18 | 218 |
| 2023 | 26 | 26 | 285 |
| 2022 | 24 | 24 | 418 |
| 2021 | 24 | 24 | 410 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
201 daysMedian, submission to acceptance · P25–P75 136 days – 273 days
- Acceptance to online
- median 34 days (56 articles)
- Submission to online
- median 244 days
- Sample
- 56 articles with submission and acceptance dates (61 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 18 weeksLetPub ·
- Submission to first decision
- 12 daysPublisher website ·
- Submission to publication (journal-reported)
- about 18 weeksDOAJ ·
- Peer review
- Open peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,390 / USD 2,890 / GBP 2,090 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,790 / EUR 2,290 / GBP 1,990 | — | — | |
| LetPub | GBP 1,890 / USD 2,690 / EUR 2,190 | Yes | — | |
| Publisher website | GBP 2,090 / USD 2,890 / EUR 2,390 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare1 items from the author guidelines
- Suggested reviewers
- Optional
Policy excerpts from the journal's websiteAI use, Data availability, License & copyright, Open access, Peer review
- AI use Large Language Models for Clinical Prediction
The advancement of large language models (LLMs) in clinical prediction represents a transformative opportunity to improve diagnostic accuracy,...
Source ↗Publisher website ·- Data availability Formatting the 'Availability of data and materials' section of your manuscript
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Diagnostic and Prognostic Research articles are published open access under a CC BY-NC-ND (Creative Commons …
Source ↗Publisher website ·- Open access Benefits of open access
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BMC
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2397-7523
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Diagnostic and Prognostic Research
What CAS zone is Diagnostic and Prognostic Research in?
In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Diagnostic and Prognostic Research?
The journal's website gives an impact factor of 3.9 (2025); this is the journal's own figure, as LetPub lists none for it; h-index 35.
How long does peer review take at Diagnostic and Prognostic Research?
Based on the dates recorded on 56 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 201 days (interquartile range 136–273 days); authors report an average review time of about 18 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Diagnostic and Prognostic Research?
According to LetPub and DOAJ records, Diagnostic and Prognostic Research is indexed in ESCI and DOAJ. The journal's website also lists CAS; that list has not been checked against each database.
Is Diagnostic and Prognostic Research open access, and what is the APC?
Diagnostic and Prognostic Research is a fully open-access journal. APC about USD 2,890.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .